Human Genome's Resistance To $2.6B GSK Offer Draws Fire
A shareholder of Human Genome Sciences Inc. on Friday asked a Maryland state court to block the biotech company's efforts to derail a $2.59 billion takeover attempt by British drugmaker GlaxoSmithKline...To view the full article, register now.
Already a subscriber? Click here to view full article